Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-28 23:47:15 - browse：244

a doctor wraps a smart watch around a patient's wrist — Adobe

As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired HumanFirst, which helps companies answer exactly those sorts of questions.

Founded in 2017, HumanFirst maintains a meticulously organized library of digital measurement tools, their underlying evidence, and information about how they have been used in clinical trials. Called Atlas, the platform is designed so that a trial sponsor can research what tools are available to measure things like physical activity or sleep for many commonly studied diseases. CEO Andy Coravos said that robust intelligence can help developers move more quickly and avoid mistakes that require costly changes to trial protocols.

Following the acquisition, HumanFirst will be another offering for Icon, which earned $8 billion last year running clinical trials for pharmaceutical companies and other related services. As of 2021, HumanFirst had raised $15 million in venture capital funding, and the decision to sell to Icon for an undisclosed amount comes as some big drug companies are reevaluating their approach to digital technologies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Wikipedia

WSS

Steward Health Care expansion into Malta flopped

Steward Health Care expansion into Malta flopped

With Wegovy coverage, Medicare patients may face high costs

Texas board proposes rules on abortion law emergency exemption

Sen. Paul opposes bill to ban Chinese biotechs

Precocious puberty in girls comes with mental health risks

knowledge

Wikipedia

entertainment

Continuity nursing helped my family in our darkest PICU moments

A deep dive into Applied Therapeutics’ data, and questions on Cassava

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

A deep dive into Applied Therapeutics’ data, and questions on Cassava

The high cost of giving birth even with insurance

U.K. officials, researchers try to ease path for bespoke genetic treatments

As demand for Covid shots wanes, Moderna seeks its next success

Change Healthcare cyberattack prompts Medicare loan program

Medicare details structure of new drug price negotiation program

Pfizer, Moderna say biotech, pharma drug development is a sprint

explore

U.K. officials, researchers try to ease path for bespoke genetic treatments

CRISPR technology availability, affordability needs to be expanded

Biotech investment managers search for lucrative opportunities

What it’s like to watch children die of measles

Readout Newsletter: Illumina, CRISPR, Regeneron

CRISPR technology availability, affordability needs to be expanded

entertainment

hotspot

Wikipedia

leisure time